Old Web
English
Sign In
Acemap
>
authorDetail
>
Sylvette Lochot
Sylvette Lochot
Antithrombotic
Medicine
Venous thrombosis
Anticoagulant
Argatroban
5
Papers
155
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Antithrombotic properties of SSR182289A, a new, orally active thrombin inhibitor
2003
Journal of Pharmacology and Experimental Therapeutics
Janine Lorrain
L. Millet
Irène Lechaire
Sylvette Lochot
Patrice Ferrari
Catherine Visconte
M. Sainte-Marie
Catherine Lunven
Christopher Berry
Paul Schaeffer
Jean-Marc Herbert
Steve O’Connor
Show All
Source
Cite
Save
Citations (24)
Antiplatelet and antithrombotic activity of SL65.0472, a mixed 5-HT1B/5-HT2A receptor antagonist.
2001
Thrombosis and Haemostasis
Christopher Berry
Janine Lorrain
Sylvette Lochot
Monique Delahaye
Alain Lalé
Pierre Savi
Irène Lechaire
Patrice Ferrari
Andre Bernat
Paul Schaeffer
Philippe Janiak
Nicole Duval
Alain Grosset
Jean-Marc Herbert
Stephen E. O'Connor
Show All
Source
Cite
Save
Citations (30)
Activity of a Sub-cutaneously Administered Novel Mixed Micellar Formulation of Argatroban in Rat and Rabbit Models of Venous Thrombosis
2000
Thrombosis and Haemostasis
Christopher Berry
Catherine Visconte
Catherine Lecoffre
Sylvette Lochot
Denise Girard
Show All
Source
Cite
Save
Citations (6)
Antithrombotic activity of argatroban in experimental thrombosis in the rabbit
1996
Seminars in Thrombosis and Hemostasis
Christopher Berry
Denise Girard
Christine Girardot
Sylvette Lochot
Catherine Lunven
Catherine Visconte
Show All
Source
Cite
Save
Citations (12)
Antithrombotic actions of argatroban in rat models of venous, ‘mixed’ and arterial thrombosis, and its effects on the tail transection bleeding time
1994
British Journal of Pharmacology
Christopher Berry
Denise Girard
Sylvette Lochot
Catherine Lecoffre
Show All
Source
Cite
Save
Citations (83)
1